RGCC SA a world-class laboratory which specialises in medical genetics and in particular cancer genetics, providing a global service. By using the most advanced and innovative technologies of molecular and cellular biology, R.G.C.C. International SA manages to overcome some of restrictions that are involved in the analysis of CTCs (Circulating Tumor Cells) and CSCs (Circulating Stem Cells). R.G.C.C. International SAs offering methods in clinical practice such as new and precise assays, risk scale and classification of cancer patients.

Read More


  • People who want to actively engage in reducing their risk of developing cancer in the future
  • People with an increased risk of cancer e.g. due to family history or lifestyle/environmental issues who want the opportunity to engage in a screening programme for early detection and diagnosis
  • People with a current diagnosis of cancer who want more information about treatment options for them as an individual – including natural treatments

Latest Info on CANCER

  • Journal of Biological Research-Thessaloniki

    Evaluation of a simple method for storage of blood samples that enables isolation of circulating tumor cells 96 h after sample collection.

  • Archives of Clinical Microbiology

    Detection and identification of bacterial contamination in blood samples from cancer patients.

  • Breast Cancer: Targets and Therapy

    Current perspectives on CHEK2 mutations in breast cancer.

  • Journal of Cancer Therapy

    Stemness Gene Profiles of Circulating Tumor Cells.

  • PLoS One

    L1 retrotransposon expression in circulating tumor cells.

  • ANTICANCER RESEARCH International Journal of Cancer Research and Treatment

    Generation of Human Antibodies Against a Specific Peptide: a Novel Strategy Based on Human Cells.

  • Molbank Journal MDPI


  • Involvement of retrotransposon L1 in stemness and cellular plasticity

    The study of Tmx2 in self-renewal and pluripotency in breast cancer



Personalized Cancer Care featuring Circulating Tumor Cell analysis

CTCs are cancer cells originated from solid tumor dispersed in the peripheral blood. It is generally explained that these cells are detached from the primary or secondary tumors of patients with advanced cancer prior to detection in the blood circulation. CTCs number is considered very less, with an estimated number of one in 100 million to one in a billion blood cells.

Read More

Circulating Tumour Cells Videos